DCOY earnings: a positive outcome, +5.1%

On August 5, 2022, Salarius Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +5.1% in the window around the event. It had already run -31.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.